The disclosure discloses a spiral-flow type fluidized-bed cooling crystallization system. The system comprises a first fluidized-bed crystallizer, a second fluidized-bed crystallizer, a crystal growing tank, a centrifuge, a circulating pump, a flow control valve, a densimeter and the like, wherein vertical heat transfer pipes are arranged in the first fluidized-bed crystallizer and the second fluidized-bed crystallizer, and scraping particles are contained in the heat transfer pipes. According to the invention, feed liquid exchanges heat with a cooling medium through the vertical heat transfer pipes; meanwhile, spiral spray heads at the bottoms of the heat transfer pipes are used for enabling the feed liquid in the pipes to form a spiral flow field, and the scraping particles are efficiently driven to continuously impact and crush crystals attached to heat transfer wall faces, so the effects of heat transfer enhancement, heat transfer wall face self-cleaning.

A system for generating a concentrated product from a feedstock includes a feedstock chamber to which the feedstock is provided, a heat exchanger assembly in thermal communication with the feedstock chamber, the heat exchanger assembly being configured to freeze the feedstock in the feedstock chamber, an output flow arrangement configured to carry liquid from the feedstock chamber as the feedstock thaws, the output flow arrangement comprising a flow controller, a sensor disposed along the output flow arrangement or the heat exchanger assembly, the sensor being configured to measure a characteristic of the liquid, the characteristic being indicative of a solute concentration level of the liquid or the heat exchanger assembly, and a processor responsive to the characteristic and configured to control the flow controller to, based on the solute concentration level, direct the liquid passing through the output flow arrangement to define a plurality of products at different concentration levels, the plurality of products comprising the concentrated product.

Disclosed is a system for producing magnesium hydroxide including: a generation unit; and a recovery unit connected to the generation unit, wherein the generation unit has a reaction tank in which a calcium hydroxide slurry is added to water to be treated containing magnesium ions to crystallize magnesium hydroxide and to obtain a reaction slurry containing particles of magnesium hydroxide, and a sedimentation tank in which the reaction slurry is reserved to sediment the particles and to separate the reaction slurry into a separation slurry containing the particles at a high concentration and a separation liquid containing the particles at a low concentration, and wherein, in the recovery unit, an alkaline aqueous solution is added to the separation liquid to crystallize magnesium hydroxide and to obtain the reaction slurry and then the reaction slurry is reserved to sediment the particles and to recover the sedimented particles.

A method of operating a crystallizing vessel assembly, said vessel assembly having a crystallizing vessel, and a rotor comprising a rotor shaft, said rotor including a plurality of rotor arms, said rotor arms having arms attached to the rotor shaft and scrapers attached at the arms. The crystals are grown on the inside of the vessel and the rotor is rotated to scrape said crystals off. To improve liquid flow inside the crystallizing vessel, a plurality of arms of the rotor arms are hollow arms, each arm of the plurality of arms including an inlet opening that is relatively close to the shaft and an outlet opening that is relatively far from the shaft.

The present invention relates to means and methods for producing crystals or crystalline substances in a contained vessel. In particular, crystals or crystalline substances, which are useful as pharmaceutical ingredients, can be manufactured.

A method of isomerizing Δ9-tetrahydrocannabinol (“Δ9-THC”) to Δ10-tetrahydrocannabinol (“Δ10-THC”). The method includes the steps of: extracting Δ9-THC from cannabis biomass, which optionally contains one or more of the components found in fire retardant such as PHOS-CHEK®; dewaxing of crude extracts by winterization; pH-adjusting extracts by washing the extracts in heptane solution with aqueous solutions of: citric acid, sodium bicarbonate, and brine; isomerizing Δ9-THC to Δ10-THC by exposure to suitable conditions and in the presence of a catalyst based on the components of fire retardant; vacuum distillation of Δ10-THC at a predetermined temperature range and vacuum level; collecting the distillate and redistilling it up to three times to acquire distillate containing less than 60% Δ10-THC; and purification of the MO-THC to a purity of 99% or greater by crystallization from n-pentane solution.

A device for purifying a product by crystallization includes: a feed unit having a solution in which the total product concentration is substantially completely dissolved or a suspension with the total product concentration; a crystallization unit in which the product crystallizes and forms a solids content; a separation unit in which the crystallized product is separated from the solution or suspension; a temperature control unit for controlling temperature at least in the feed unit and/or the crystallization unit; and a control and evaluation unit that determines the total product concentration and/or the concentration of the solids content and/or the concentration of the dissolved product content and/or the concentration of an impurity content, taking into account the measured values of connected temperature sensors and of connected impedance sensors.

Methods are disclosed for producing highly purified recombinant human insulin (RHI) having a purity of 99.0% (w/w) or greater, a Total Impurity (not including the related substance desamido Asn.sup.A21-RHI, as specified by USP) of 0.8% (w/w) or less, and an impurity C of 0.1% (w/w) or less. Also disclosed are API compositions of highly purified RHI having a purity of 99.0% (w/w) or greater, a Total Impurity of 0.8% (w/w) or less, and an impurity C of 0.1% (w/w) or less.

Disclosed is an external circulating slurry reactive crystallizer, including a riser, a degassing zone and a downcomer. A lower end of the riser is communicated with a gas inlet pipe, a liquid inlet pipe and a solid feeding pipe, while an upper end of the riser is communicated with a lower end of the degassing zone. An upper end of the downcomer is integrally fixed to a sidewall of the degassing zone. At least one hydrocyclone is arranged at a lower end of the downcomer. The hydrocyclone is provided with an overflow port at an upper end thereof and an underflow port and a valve at a lower end thereof. The overflow port is communicated with the riser. The crystallizer can simultaneously realize reaction, crystallization and separation for continuous production with low cost, regulating and controlling the particle size distribution and morphology of crystals.

Techniques according to the present disclosure include capturing carbon dioxide from a dilute gas source with a CO.sub.2 capture solution to form a carbonate-rich capture solution; separating at least a portion of carbonate from the carbonate-rich capture solution; forming an electrodialysis (ED) feed solution; flowing a water stream and the ED feed solution to a bipolar membrane electrodialysis (BPMED) unit; applying an electric potential to the BPMED unit to form at least two ED product streams including a first ED product stream including a hydroxide; and flowing the first ED product stream to use in the capturing the carbon dioxide from the dilute gas source with the CO.sub.2 capture solution.